Senators launch probe into why price of cancer drug increased 1400 percent

The Hill

2 April 2018 - Three U.S. senators are asking why a 40-year-old cancer drug has increased in price by 1,400 percent since 2013.

The drug in question, lomustine, was introduced in 1976 to treat brain tumors and Hodgkin lymphoma.

Lomustine, which has no generic competition, cost $50 for a capsule with the highest dose in 2013. Now a capsule with the same dose costs $768.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing